Clinical Trial

A Study of AK146D1 for Injection in Advanced Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK146D1 for injection in advanced solid tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-13.
Status change: Not Yet Recruiting → Recruiting 2025-09-01
Trial Details
NCT Number NCT07067567
Lead Sponsor Akeso
Conditions Advanced Solid Tumors
Enrollment 200 participants
Start Date 2025-08-07
Primary Completion 2026-11-05 (estimated)
Study Completion 2027-05-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-03